Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present ObsEva SA (NASDAQ: OBSV).

Full DD Report for OBSV

You must become a subscriber to view this report.


Recent News from (NASDAQ: OBSV)

ObsEva Reports Third Quarter 2018 Financial Results and Provides Business Update
IMPLANT 4 trial of nolasiban in IVF starting in Q4 2018, European MAA filing expected late 2019   24-week data from Phase 2b EDELWEISS clinical trial of linzagolix in endometriosis supports 75mg without ABT and 200mg with low dose ABT for Phase 3 trials planned for 2019 &...
Source: GlobeNewswire
Date: November, 07 2018 20:15
5 European Biotech Bargains
Introduction European biotech stocks have a lower valuation in general than American biotechs. It is an observation that many sector followers have already made. In my opinion the cause can be found in the overall ecosystem for biotech. In the United States there is more appetite for this pa...
Source: SeekingAlpha
Date: November, 07 2018 12:08
ObsEva SA to Participate in November Investor Conferences
Geneva, Switzerland and Boston, MA – November 7, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive healt...
Source: GlobeNewswire
Date: November, 06 2018 20:30
ObsEva SA to Hold Third Quarter 2018 Financial Results and Business Update Call on November 8, 2018
Geneva, Switzerland and Boston, MA –October 31, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproduct...
Source: GlobeNewswire
Date: October, 30 2018 22:30
Premarket analyst action - healthcare
CytomX Therapeutics (NASDAQ: CTMX ) initiated with Buy rating and $32 (68% upside) price target at H.C. Wainwright citing bullish prospects for Probody platform. More news on: CytomX Therapeutics, Rocket Pharmaceuticals, Inc., ObsEva, Healthcare stocks news, Stocks on the move, , Read ...
Source: SeekingAlpha
Date: September, 13 2018 08:28
ObsEva SA to Participate in September Investor Conferences
Geneva, Switzerland and Boston, MA – August 28, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health...
Source: GlobeNewswire
Date: August, 27 2018 21:30
New Research: Key Drivers of Growth for ObsEva SA, Gran Tierra Energy, Constellium N.V, Just Energy Group, Hovnanian Enterprises, and First Majestic Silver - Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, Aug. 21, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ObsEva SA (NASDAQ:OBSV), Gran Tierra Energy Inc. (NYSE:GTE), Constellium ...
Source: GlobeNewswire
Date: August, 21 2018 08:25
Obseva SA (OBSV) CEO Ernest Loumaye on Q2 2018 Results - Earnings Call Transcript
Obseva SA (OBSV) Q2 2018 Earnings Conference Call August 08, 2018, 08:00 ET Executives Mario Corso - Senior Director, IR Ernest Loumaye - Co-Founder, CEO & Director Timothy Adams - CFO Analysts Martin Auster - Crédit Suisse Kennen MacKay - RBC Capital Markets R...
Source: SeekingAlpha
Date: August, 11 2018 10:42
ObsEva SA to Participate in Wedbush PacGrow Healthcare Conference August 14-15, 2018
Geneva, Switzerland and Boston, MA - August 10, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pre...
Source: GlobeNewswire
Date: August, 10 2018 01:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-1415.4914.8615.5014.75557,397

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-078,75649,38117.7315Cover
2018-12-064,39811,75737.4075Short
2018-12-044,9519,29853.2480Short
2018-12-0317,44824,52071.1582Short
2018-11-302,5359,37727.0342Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on OBSV.


About ObsEva SA (NASDAQ: OBSV)

Logo for ObsEva SA (NASDAQ: OBSV)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $493,845,785 - 05/18/2018
  • Issue and Outstanding: 37,131,262 - 12/31/2017

 


Recent Filings from (NASDAQ: OBSV)

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: August, 08 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: July, 25 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: July, 06 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: June, 22 2018
Prospectus filed under Rule 424(b)(5)
Filing Type: 424B5Filing Source: edgar
Filing Date: June, 20 2018
Prospectus filed under Rule 424(b)(5)
Filing Type: 424B5Filing Source: edgar
Filing Date: June, 19 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: June, 18 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: May, 16 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: April, 16 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: March, 30 2018

 

 


Daily Technical Chart for (NASDAQ: OBSV)

Daily Technical Chart for (NASDAQ: OBSV)


Stay tuned for daily updates and more on (NASDAQ: OBSV)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: OBSV)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in OBSV is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of OBSV and does not buy, sell, or trade any shares of OBSV. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/